Essential Elements of Personalized Analgesic Medications
Essential Elements of Personalized Analgesic Medications
Essential Elements of Personalized Analgesic Medications

Essential Elements of Personalised Analgesic Medications

ACTIVITY DESCRIPTION

Analgesic therapies present particular issues and challenges to the physicians and pharmacists. The practice-based activity will provide general practitioners and pharmacists with the opportunity to enhance their competency as it relates to the many therapeutic options used in analgesic therapies. Having been presented with a prescription indicating a need for a medication, the participants will use uniquely designed patient assessment tools, select appropriate delivery systems for the specific analgesics and nutritional supplements prescribed, and then monitor patient progress.

During this process the participants will have learned how to relate drug mechanisms of action to physiological and pathophysiological pathways responsible for the elicitation of a pain response, how to conduct a patient needs analysis and then work collaboratively to provide expertise with respect to the therapeutic, concomitant adjuvant, and lifestyle and behavior modification options available to the physician.

Finally, participants will apply monitoring tools and strategies to maintain patient compliance with prescribed analgesic initiatives. Case work will be documented and clinical findings recorded in a formal manner for purposes of confidential communication, record keeping and statistical analysis.

INTENDED AUDIENCE

General practitioners and pharmacists engaged in prescription analgesic therapies.

ACTIVITY DESIGN

Predisposing activity.
A live event with casework.
Reinforcing activity (physicians only).

LEARNING OBJECTIVES OF PREDISPOSING ACTIVITY

  1. Review the basic structure and function of the nervous syste
  2. Relate physiological and biochemical features of signal transmission and transduction of nerve impulses
  3. Describe the anatomy and physiology of the pathways involved in nociceptive and neurogenic pain
  4. Explain the mechanisms of peripheral and central sensitization and how they relate to acute and chronic pain
  5. Describe the contributing factors to pathophysiological pathways including cognitive mechanisms, nociceptive responses, wind-up, and central sensitization
  6. Identify pharmacological targets for the treatment of pain

OVERALL LEARNING OBJECTIVES OF LIVE EVENT

  1. Employ customised principles and techniques of analgesic formulation-related delivery systems
  2. Identify and develop novel targeting approaches to physiological and pathophysiological pathways
  3. Relate physiological and biochemical features of signal transmission and transduction
  4. Interpret deleterious signal elicitation and subsequent excitation, inhibition, cessation and modulation though analgesic therapy
  5. Assess the various routes of delivery, delivery systems, dosage forms and dispensing mechanisms used in analgesic therapy, adjunct therapy, supplementation and specific aspects of lifestyle management
  6. Evaluate and select therapeutic alternatives for specific classifications related to analgesic therapy; specifically formulations which may be prescribed or used by the physician in the treatment of nociception, neuropathology, neuromas, centralisation, direct and indirect consequences of vascular deprivation, neural budding and plasticity
  7. Review comprehensive patient assessment chart data; includes prior medical history, familial history, differential diagnoses, lifestyle behaviors, signs and symptoms, laboratory test results, and analgesic-related medication, adjunct pharmacotherapeutic and supplementation treatments. Interpret and apply this resource

PHARMACIST COMPETENCIES

DOMAIN 1: Professional and Ethical Practice

  • Standard 1.3 - Deliver ‘patient-centred’ care: focus on consumer; address consumer needs

DOMAIN 4: Review and Supply Prescribed Medicines

  • Standard 4.2 - Consider appropriateness of prescribed medicines: gather relevant information; review prescribed medicines; promote optimal medication
  • Standard 4.3 - Dispense prescribed medicines: apply systematic dispensing procedure, manage records, assist consumer understanding

DOMAIN 5: Prepare Pharmaceutical Products

  • Standard 5.1 - Consider product requirements: consider legislative and professional obligations; consider need for product; confirm required information; confirm required formulation; determine if production requirements can be met; prepare and maintain product documentation; optimise packing and labelling

DOMAIN 6: Deliver Primary and Preventive Health Care

  • Standard 6.1 - Assess primary health care needs: Assess primary health care needs: elicit clinical information; identify management options, initiate collaboration or onward referral
  • Standard 6.2 - Deliver primary health care: ensure clinical appropriateness of medicines and health care products; promote safe and effective use of medicines; support non-medicinal management options; provide direct care consistent with role of pharmacist; manage records for primary health care services

DOMAIN 7: Promote and Contribute to Optimal Use of Medicines

  • Standard 7.1 - Contribute to therapeutic decision-making: obtain accurate medication history; assess current medication management; recommend change in medication management; support and assist consumer self-management

ACCREDITATION

This activity has been accredited for 23 hours and 46 Group 2 CPD credits upon successful completion of assessment. These credits are suitable for inclusion on an individual pharmacist’s CPD plan. For physicians, the above mentioned training activity may be applicable towards self-directed QI & CPD as part of a structured learning plan.

APC Accredited CPD

A1701MED1 (Sydney): The activity accreditation period is from 4 April 2017 – 4 April 2019.

A1701MED2 (Melbourne): The activity accreditation period is from 4 April 2017 – 4 April 2019.

RACGP

90830: The activity accreditation period is from 1 January 2017 - 31 December 2019.

EDITORS

PATRICIA ULLMANN

CPD Coordinator and Compounding Pharmacist, MEDISCA Australia.

CONTRIBUTORS

MIGUEL DE LA GARZA, MD, DABA, DABPM

Diplomate of the American Board of Pain Medicine, Diplomate of the American Board of Anesthesiology.

MARK FILOSI, BS Pharm, RPh

Compounding Pharmacist and Co-Founder, Family Care Pharmacy.

KENNETH LATTA, BS Pharm, RPh, FIACP, FACA

Senior Associate, Gates Healthcare Associates.

KEN SPEIDEL, BS Pharm, PharmD, RPh, FIACP, FACA

Senior Associate, Gates Healthcare Associates.


FACILITATORS

KEN SPEIDEL, BS Pharm, PharmD, RPh, FIACP, FACA

Senior Associate, Gates Healthcare Associates.
Independent industry consultant to organisations in North America and Senior Associate for; Gates Healthcare Associates and Health System Consulting Group; Specialty Training in Functional Medicine, Endocrinology, Pain Management and Aseptic compounding; Surveyor and Standards Committee member for PCAB.

DR LILY TOMAS, MD, MBBS(UNSW), RACGP

Dr Lily Tomas is an Integrative Medical Doctor practicing on the Sapphire Coast in NSW, Australia with over 20 years' experience in treating all aspects of Health. Dr Tomas is a Fellow of the Australasian College of Nutrition and Environmental Medicine (ACNEM) and Past President of the Australian Integrative Medical Association (AIMA). Dr Tomas was the founding Editor of Advances in Integrative Medicine, Elsevier. Dr Tomas has also had the pleasure of lecturing at many renowned organizations and associations, including AIMA, ACNEM, Australasian Academy of Anti-Aging Medicine (A5M), Australian Lifestyle Medicine Association (ALMA), BioBalance Health Australia, MINDD Foundation, Australian Acupuncture & Chinese Medicine Association (AACMA), University of Western Sydney- Medicine Faculty, Royal Australian College of General Practitioners (RACGP), and the McGrath Foundation- Breast Cancer.

COPYRIGHT

Activity material is Copyright© 2008-2017 LP3 Network Inc.

COMPLETION REQUIREMENTS

Full attendance and the completion of an activity evaluation and practical skill set competency evaluation are a compulsory requirement to achieve credit for the live event.

DECLARATIONS AND DISCLOSURES

It is a requirement of the Australian Pharmacy Council Accreditation Standards for Continuing Professional Development Activities that full disclosure of conflicts of interest be made available to participants. This activity is independent of any known bias, prejudice or commercial interest. Both MEDISCA Australia and LP3 Network Inc. assist with the marketing of this activity. LP3 Network Inc. is an independent corporation. LP3 Network Inc. has an established agreement with MEDISCA Australia ensuring that it has no influence on LP3 Network Inc. as it relates to activity offerings.

FINANCIAL SUPPORT

An unrestricted educational grant for this activity has been provided by MEDISCA Inc.

HOTEL ACCOMMODATIONS

Special rates for hotel accommodations have been arranged for activity participants. Payment for hotel accommodations is at the expense of the activity participant.

FOOD AND BEVERAGE

As a matter of activity programming, meals and refreshments during live activities have been provided by MEDISCA Australia.

CANCELLATION AND REFUND POLICY

A written request must be sent to MEDISCA Australia requesting a ‘Cancellation without Transfer’ to an alternate live activity event date. If cancellation occurs at greater than or equal to 31 days from the live activity event date, then the registrant will receive a 75% refund; 15- 30 days is a 50% refund; and less than or equal to 14 days will result in no refund.

TRANSFER POLICY

The transfer policy is only in effect if requested greater than or equal to 14 days prior to original live activity event date. Failure to submit the “Transfer Request” at least 14 days prior to original live activity event date will default to the “Cancellation and Refund Policy”. The transfer policy can only be applied one (1) time. Transfer to a new live activity event date must be within the current calendar year. Failure to attend the new live activity event will result in no refund and will no longer be transferable. Confirmation of the new activity date is subject to approval by MEDISCA Australia based on the number of available seats within the selected live activity event.


GO BACK


X

We have placed cookies on your device to help make this website better.

We also use cookies to collect information for making reports and to help us improve the site. The cookies collect information in an anonymous form.



Copyright® 1986-2019 Medisca Inc.
All rights reserved

MEDISCA is ISO 9001:2008 certified